Dandan Wang, K. Myers, E. Bresnick, J. Verbsky, M. Thakar, S. Malarkannan
{"title":"GATA2-TGF-b1轴调控人NK细胞发育","authors":"Dandan Wang, K. Myers, E. Bresnick, J. Verbsky, M. Thakar, S. Malarkannan","doi":"10.4049/jimmunol.210.supp.162.02","DOIUrl":null,"url":null,"abstract":"\n Natural killer (NK) cells, a subset of innate lymphocytes, produce proinflammatory cytokines and mediate anti-tumor cytotoxicity. GATA2 is a master transcription factor that is essential for the development of erythroid, myeloid, B, and NK cells. Patients with GATA2 haploinsufficiency lack CD56 brightNK cells (immature), with or without a reduction in the number of CD56 dimNK cells (mature). However, how GATA2 functions to establish and maintain genetic networks during the development and function of human NK cells is unknown. Here, we identify a novel GATA2-TGF-b1 axis that regulates NK cell development. We performed single-cell RNA-seq with NK cells from three GATA2 T354Mpatients and found significantly reduced expression of immediate early genes, which indicated that they are functionally-defective. We discovered a reduction in TGF-b1 transcripts and defective expression of TGF-b1 target genes in NK cells from GATA2 T354Mpatients. Using a reporter assay, we determined that GATA2 occupy to TGFB1 promoter, and this association was decreased in GATA2 T354MNK cells. ATAC-seq of GATA2 T354MNK cells indicates significantly altered chromatin accessibility. GATA2 CUT&Tag-seq validated that it occupies the TGFB1 promoter region, which correlated with activation of the TGFB1 locus in human NK cells. In summary, we define a mechanism by which GATA2 controls TGF-b1 production in human NK cells and thereby regulating their development. These findings provide vital clues for developmental and functional defects of NK cells in GATA2 T354Mpatients.\n ASH Graduate Hematology Award (D.W.); GIRT Award from MCW-C4I (D.W.); NIH R01 AI102893 and NCI R01 CA179363 (S.M.); HRHM Program of MACC Fund (S.M.), Nicholas Family Foundation (S.M.); Gardetto Family (S.M.); MCW-Cancer Center-Large Seed Grant (S.M. and M.S.T.); MACC Fund (S.M.); Ann’s Hope Mela- noma Foundation (S.M.); and Advancing Healthier Wisconsin (S.M.)","PeriodicalId":22698,"journal":{"name":"The Journal of Immunology","volume":"88 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"GATA2-TGF-b1 axis regulates human NK cell development\",\"authors\":\"Dandan Wang, K. Myers, E. Bresnick, J. Verbsky, M. Thakar, S. Malarkannan\",\"doi\":\"10.4049/jimmunol.210.supp.162.02\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n Natural killer (NK) cells, a subset of innate lymphocytes, produce proinflammatory cytokines and mediate anti-tumor cytotoxicity. GATA2 is a master transcription factor that is essential for the development of erythroid, myeloid, B, and NK cells. Patients with GATA2 haploinsufficiency lack CD56 brightNK cells (immature), with or without a reduction in the number of CD56 dimNK cells (mature). However, how GATA2 functions to establish and maintain genetic networks during the development and function of human NK cells is unknown. Here, we identify a novel GATA2-TGF-b1 axis that regulates NK cell development. We performed single-cell RNA-seq with NK cells from three GATA2 T354Mpatients and found significantly reduced expression of immediate early genes, which indicated that they are functionally-defective. We discovered a reduction in TGF-b1 transcripts and defective expression of TGF-b1 target genes in NK cells from GATA2 T354Mpatients. Using a reporter assay, we determined that GATA2 occupy to TGFB1 promoter, and this association was decreased in GATA2 T354MNK cells. ATAC-seq of GATA2 T354MNK cells indicates significantly altered chromatin accessibility. GATA2 CUT&Tag-seq validated that it occupies the TGFB1 promoter region, which correlated with activation of the TGFB1 locus in human NK cells. In summary, we define a mechanism by which GATA2 controls TGF-b1 production in human NK cells and thereby regulating their development. These findings provide vital clues for developmental and functional defects of NK cells in GATA2 T354Mpatients.\\n ASH Graduate Hematology Award (D.W.); GIRT Award from MCW-C4I (D.W.); NIH R01 AI102893 and NCI R01 CA179363 (S.M.); HRHM Program of MACC Fund (S.M.), Nicholas Family Foundation (S.M.); Gardetto Family (S.M.); MCW-Cancer Center-Large Seed Grant (S.M. and M.S.T.); MACC Fund (S.M.); Ann’s Hope Mela- noma Foundation (S.M.); and Advancing Healthier Wisconsin (S.M.)\",\"PeriodicalId\":22698,\"journal\":{\"name\":\"The Journal of Immunology\",\"volume\":\"88 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Journal of Immunology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4049/jimmunol.210.supp.162.02\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Immunology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4049/jimmunol.210.supp.162.02","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
自然杀伤(NK)细胞,先天淋巴细胞的一个子集,产生促炎细胞因子和介导抗肿瘤细胞毒性。GATA2是一种主转录因子,对红细胞、髓细胞、B细胞和NK细胞的发育至关重要。GATA2单倍体功能不全患者缺乏CD56亮nk细胞(未成熟),CD56暗nk细胞(成熟)数量减少或不减少。然而,在人类NK细胞的发育和功能过程中,GATA2如何建立和维持遗传网络尚不清楚。在这里,我们发现了一个新的GATA2-TGF-b1轴调节NK细胞的发育。我们对三名GATA2 t354m患者的NK细胞进行了单细胞rna测序,发现直接早期基因的表达显著降低,这表明它们存在功能缺陷。我们发现来自GATA2 t354m患者的NK细胞中TGF-b1转录物减少,TGF-b1靶基因表达缺陷。通过报告子实验,我们确定GATA2占据TGFB1启动子,并且这种关联在GATA2 T354MNK细胞中减少。GATA2 T354MNK细胞的ATAC-seq显示染色质可及性显著改变。GATA2 CUT&Tag-seq验证其占据TGFB1启动子区域,该区域与人NK细胞中TGFB1位点的激活相关。总之,我们确定了GATA2控制人类NK细胞中TGF-b1产生从而调节其发育的机制。这些发现为研究GATA2 t354m患者NK细胞的发育和功能缺陷提供了重要线索。ASH研究生血液学奖(D.W.);MCW-C4I (D.W.)女孩奖;NIH R01 AI102893和NCI R01 CA179363 (S.M.);MACC基金(S.M.)、Nicholas Family Foundation (S.M.) HRHM项目;加德托家族(S.M.);mcw -癌症中心-大型种子基金(S.M.和M.S.T.);反贪会基金;安的希望梅拉诺玛基金会(S.M.);和促进健康威斯康星州(S.M.)
GATA2-TGF-b1 axis regulates human NK cell development
Natural killer (NK) cells, a subset of innate lymphocytes, produce proinflammatory cytokines and mediate anti-tumor cytotoxicity. GATA2 is a master transcription factor that is essential for the development of erythroid, myeloid, B, and NK cells. Patients with GATA2 haploinsufficiency lack CD56 brightNK cells (immature), with or without a reduction in the number of CD56 dimNK cells (mature). However, how GATA2 functions to establish and maintain genetic networks during the development and function of human NK cells is unknown. Here, we identify a novel GATA2-TGF-b1 axis that regulates NK cell development. We performed single-cell RNA-seq with NK cells from three GATA2 T354Mpatients and found significantly reduced expression of immediate early genes, which indicated that they are functionally-defective. We discovered a reduction in TGF-b1 transcripts and defective expression of TGF-b1 target genes in NK cells from GATA2 T354Mpatients. Using a reporter assay, we determined that GATA2 occupy to TGFB1 promoter, and this association was decreased in GATA2 T354MNK cells. ATAC-seq of GATA2 T354MNK cells indicates significantly altered chromatin accessibility. GATA2 CUT&Tag-seq validated that it occupies the TGFB1 promoter region, which correlated with activation of the TGFB1 locus in human NK cells. In summary, we define a mechanism by which GATA2 controls TGF-b1 production in human NK cells and thereby regulating their development. These findings provide vital clues for developmental and functional defects of NK cells in GATA2 T354Mpatients.
ASH Graduate Hematology Award (D.W.); GIRT Award from MCW-C4I (D.W.); NIH R01 AI102893 and NCI R01 CA179363 (S.M.); HRHM Program of MACC Fund (S.M.), Nicholas Family Foundation (S.M.); Gardetto Family (S.M.); MCW-Cancer Center-Large Seed Grant (S.M. and M.S.T.); MACC Fund (S.M.); Ann’s Hope Mela- noma Foundation (S.M.); and Advancing Healthier Wisconsin (S.M.)